Work

Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct

Year: 2020

Type: article

Abstract: Drug-induced liver injury (DILI) is an uncommon adverse drug reaction of increasing importance to the medical community, pharmaceutical industry, regulatory agencies and the general public.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/yrfh-p349

Authors: Bonkovsky, Herbert L., Watkins, Paul B., Serrano, Jose, Davern, Timothy, Chalasani, Naga, Rochon, James, Fontana, Robert J.

Language: English

Topic: Drug-Induced Hepatotoxicity and Protection

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G3164544486, G496010787, G678480494, G6970613385, G9000007973, University of North Carolina Clinical Center for DILIN

OpenAlex ID: W4299318342

FWCI: 4.86

Cites:

Cited by: 45

Related to: 10